Can FDG PET/CECT accurately restage patients of stomach carcinoma?

J Paudel, T Jain, R Kumar, B Mittal, A Bhattacharya… - 2017 - Soc Nuclear Med
495 Objectives: To evaluate the diagnostic performance of contract enhanced F-18 FDG
PET/CT in restaging of stomach carcinoma patients. Methods: We retrospectively analyzed …

One-year post-operative evaluation of stomach cancer using FDG PET/CT in patients with low suspicion of recurrence

DY Lee, M Seo, JS Ryu, JJ Lee - 2013 - Soc Nuclear Med
1497 Objectives The purpose of this study was to see the clinical need of 1-year post-
operative FDG-PET/CT in stomach cancer patients. Methods From June 2011 to June 2012 …

The role of 18F-FDG PET/CT in the assessment of suspected recurrent gastric cancer after initial surgical resection: can the results of FDG PET/CT influence patients' …

A Bilici, BBO Ustaalioglu, M Şeker, U Kefeli… - European journal of …, 2011 - Springer
Abstract Purpose 18 F-fluorodeoxyglucose (FDG) PET/CT has been widely used for staging,
re-staging and for monitoring therapy-induced changes and response to therapy in patients …

Value of {sup 18} F-FDG PET/CT in detecting recurrence and metastasis in gastric carcinoma

M Li, Y Guoren, F Zheng, H Anqing, Z Jinsun… - Chinese Journal of …, 2009 - osti.gov
Objective: PET with {sup 18} F-fluorodeoxyglucose (FDG) has been used to beth detect and
stage a variety of malignancies. The aim of this retrospective study was to evaluate the …

Primary Tumor FDG Avidity Influences the Performance of FDG PET/CT for Detecting Gastric Cancer Recurrence Following Curative Surgery

SJ Kim, SB Park, E Jeong, SH Hyun, SH Moon, YS Cho… - 2015 - Soc Nuclear Med
638 Objectives The outcome of advanced gastric cancer remains poor, and early detection
of recurrence is important. We hypothesized that heterogeneity of gastric cancer biology …

Clinical impact of FDG-PET in the follow-up or suspicion of recurrent gastric cancer

Y Nakamoto, T Saga, T Higashi, T Hara, T Suga… - 2008 - Soc Nuclear Med
1469 Objectives: To evaluate the clinical contribution of positron emission tomography (PET)
using 18 F-fluorodeoxyglucose (FDG) in patients with follow-up or suspected recurrent …

Validity of F-18 FDG-PET/CT and contrast-enhanced MDCT in detecting recurred gastric cancer: Analysis according to individual lesions

JM Ha, SY Jeong, YS Seo, SY Kwon, A Chong, JJ Min… - 2008 - Soc Nuclear Med
1487 Objectives: We assessed diagnostic accuracy of F-18 FDG-PET/CT (PET/CT) and
contrast-enhanced MDCT (CECT) in detecting tumor recurrence of gastric cancer. Methods …

Diagnosis of recurrent gastric cancer using combination of FDG-PET and CT: Compared with CT, and serum tumor marker level

K Shibata, K Uno, W Ko, J Wu - 2008 - Soc Nuclear Med
231 Objectives: To date, there are few studies about FDG-PET for recurrent gastric cancer.
So we assessed usefulness of FDG-PET in combination with CT for the diagnosis of gastric …

Value of 18F-FDG PET/CT in detecting recurrence and metastasis in gastric carcinoma

L Ma, G Yang, Z Fu, A Han, J Zhen, S Zhao… - Chinese Journal of …, 2009 - inis.iaea.org
[en] Objective: PET with 18 F-fluorodeoxyglucose (FDG) has been used to beth detect and
stage a variety of malignancies. The aim of this retrospective study was to evaluate the …

[HTML][HTML] The role of 18F-FDG PET/CT in the evaluation of gastric cancer recurrence

H Cayvarlı, R Bekiş, T Akman… - Molecular imaging and …, 2014 - ncbi.nlm.nih.gov
Objective: F-18-fluorodeoxyglucose positron emission tomography/computed tomography
(18F-FDG PET/CT) has been widely used for staging, re-staging and for monitoring therapy …